Avelumab and Pepinemab
SGIP21027
Phase 2 small_molecule active
Quick answer
Avelumab and Pepinemab for Metastatic Pancreatic Adenocarcinoma is a Phase 2 program (small_molecule) at VACCINEX, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VACCINEX, INC.
- Indication
- Metastatic Pancreatic Adenocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active